Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Microorganisms ; 4(3)2016 Sep 20.
Article in English | MEDLINE | ID: mdl-27681928

ABSTRACT

Biofilms formed by Staphylococcus aureus is a serious complication to the use of medical implants. A central part of the pathogenesis relies on S. aureus' ability to adhere to host extracellular matrix proteins, which adsorb to medical implants and stimulate biofilm formation. Being coagulase positive, S. aureus furthermore induces formation of fibrin fibers from fibrinogen in the blood. Consequently, we hypothesized that fibrin is a key component of the extracellular matrix of S. aureus biofilms under in vivo conditions, and that the recalcitrance of biofilm infections can be overcome by combining antibiotic treatment with a fibrinolytic drug. We quantified S. aureus USA300 biofilms grown on peg-lids in brain heart infusion (BHI) broth with 0%-50% human plasma. Young (2 h) and mature (24 h) biofilms were then treated with streptokinase to determine if this lead to dispersal. Then, the minimal biofilm eradication concentration (MBEC) of 24 h old biofilms was measured for vancomycin and daptomycin alone or in combination with 10 µg/mL rifampicin in the presence or absence of streptokinase in the antibiotic treatment step. Finally, biofilms were visualized by confocal laser scanning microscopy. Addition of human plasma stimulated biofilm formation in BHI in a dose-dependent manner, and biofilms could be partially dispersed by streptokinase. The biofilms could be eradicated with physiologically relevant concentrations of streptokinase in combination with rifampicin and vancomycin or daptomycin, which are commonly used antibiotics for treatment of S. aureus infections. Fibronolytic drugs have been used to treat thromboembolic events for decades, and our findings suggest that their use against biofilm infections has the potential to improve the efficacy of antibiotics in treatment of S. aureus biofilm infections.

2.
Soft Matter ; 11(26): 5327-35, 2015 Jul 14.
Article in English | MEDLINE | ID: mdl-26054328

ABSTRACT

We report on Janus subcompartmentalized assemblies with enzyme loaded liposomes entrapped within a polymer carrier capsule - Janus subcompartmentalized microreactors. The concept is based on the use of Pickering emulsions and the subsequent deposition of interacting liposomes and polymer layers. We demonstrate the adjustment of the size of the Janus domains and the control over the amount of trapped liposomes using multiple liposome deposition steps. The obtained Janus capsosomes feature a distinct liposome domain within a closed polymeric hydrogel shell. The assembly of functional Janus microreactors using trypsin as cargo within the liposomal subcompartments is shown by performing locally confined enzymatic encapsulated catalysis. The presented assemblies with spatial control over the position of their liposomal subunits are a fascinating first step towards artificial cells with polarity.


Subject(s)
Liposomes/chemistry , Microtechnology , Polymers/chemistry , Animals , Catalysis , Cattle , Hydrogels/chemistry , Membranes, Artificial , Models, Molecular , Molecular Conformation , Polymethacrylic Acids/chemistry , Silicon Dioxide/chemistry , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...